Remember to add your abstract to your poster! Also, bonus points can be awarded for a good, professional presentation. Go ahead and practice presenting your poster with your teammates before symposium ...
PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included ...
PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at ...
TYRA-430 is an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers. The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to ...
Trump has used the tariffs as a negotiating tool and a way to protect US industry, and has repeatedly railed against the ...
As the Trump administration publicly hammers out its plans on the Ukraine war, it's also pressing Ukraine for deals in ...
Brian Kearney; Vice President, Investor Relations; Oatly Group AB (publ) Jean-Christophe Flatin; Chief Executive Officer; Oatly Group AB (publ) Daniel Ordonez; Chief ...
The President's Emergency Plan for AIDS Relief received a waiver from the Trump administration's initial stop-work order for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results